Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Panitumumab market report explains the definition, types, applications, major countries, and major players of the Panitumumab market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Amgen
By Type:
100 mg/5 mL single-dose vials
400 mg/20 mL single-dose vials
By End-User:
Hospital
Drug Stores
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Panitumumab Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Panitumumab Outlook to 2028- Original Forecasts
-
2.2 Panitumumab Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Panitumumab Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Panitumumab Market- Recent Developments
-
6.1 Panitumumab Market News and Developments
-
6.2 Panitumumab Market Deals Landscape
7 Panitumumab Raw Materials and Cost Structure Analysis
-
7.1 Panitumumab Key Raw Materials
-
7.2 Panitumumab Price Trend of Key Raw Materials
-
7.3 Panitumumab Key Suppliers of Raw Materials
-
7.4 Panitumumab Market Concentration Rate of Raw Materials
-
7.5 Panitumumab Cost Structure Analysis
-
7.5.1 Panitumumab Raw Materials Analysis
-
7.5.2 Panitumumab Labor Cost Analysis
-
7.5.3 Panitumumab Manufacturing Expenses Analysis
8 Global Panitumumab Import and Export Analysis (Top 10 Countries)
-
8.1 Global Panitumumab Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Panitumumab Export by Region (Top 10 Countries) (2017-2028)
9 Global Panitumumab Market Outlook by Types and Applications to 2022
-
9.1 Global Panitumumab Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 100 mg/5 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 400 mg/20 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
9.2 Global Panitumumab Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Stores Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Panitumumab Market Analysis and Outlook till 2022
-
10.1 Global Panitumumab Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Panitumumab Consumption (2017-2022)
-
10.2.2 Canada Panitumumab Consumption (2017-2022)
-
10.2.3 Mexico Panitumumab Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Panitumumab Consumption (2017-2022)
-
10.3.2 UK Panitumumab Consumption (2017-2022)
-
10.3.3 Spain Panitumumab Consumption (2017-2022)
-
10.3.4 Belgium Panitumumab Consumption (2017-2022)
-
10.3.5 France Panitumumab Consumption (2017-2022)
-
10.3.6 Italy Panitumumab Consumption (2017-2022)
-
10.3.7 Denmark Panitumumab Consumption (2017-2022)
-
10.3.8 Finland Panitumumab Consumption (2017-2022)
-
10.3.9 Norway Panitumumab Consumption (2017-2022)
-
10.3.10 Sweden Panitumumab Consumption (2017-2022)
-
10.3.11 Poland Panitumumab Consumption (2017-2022)
-
10.3.12 Russia Panitumumab Consumption (2017-2022)
-
10.3.13 Turkey Panitumumab Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Panitumumab Consumption (2017-2022)
-
10.4.2 Japan Panitumumab Consumption (2017-2022)
-
10.4.3 India Panitumumab Consumption (2017-2022)
-
10.4.4 South Korea Panitumumab Consumption (2017-2022)
-
10.4.5 Pakistan Panitumumab Consumption (2017-2022)
-
10.4.6 Bangladesh Panitumumab Consumption (2017-2022)
-
10.4.7 Indonesia Panitumumab Consumption (2017-2022)
-
10.4.8 Thailand Panitumumab Consumption (2017-2022)
-
10.4.9 Singapore Panitumumab Consumption (2017-2022)
-
10.4.10 Malaysia Panitumumab Consumption (2017-2022)
-
10.4.11 Philippines Panitumumab Consumption (2017-2022)
-
10.4.12 Vietnam Panitumumab Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Panitumumab Consumption (2017-2022)
-
10.5.2 Colombia Panitumumab Consumption (2017-2022)
-
10.5.3 Chile Panitumumab Consumption (2017-2022)
-
10.5.4 Argentina Panitumumab Consumption (2017-2022)
-
10.5.5 Venezuela Panitumumab Consumption (2017-2022)
-
10.5.6 Peru Panitumumab Consumption (2017-2022)
-
10.5.7 Puerto Rico Panitumumab Consumption (2017-2022)
-
10.5.8 Ecuador Panitumumab Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Panitumumab Consumption (2017-2022)
-
10.6.2 Kuwait Panitumumab Consumption (2017-2022)
-
10.6.3 Oman Panitumumab Consumption (2017-2022)
-
10.6.4 Qatar Panitumumab Consumption (2017-2022)
-
10.6.5 Saudi Arabia Panitumumab Consumption (2017-2022)
-
10.6.6 United Arab Emirates Panitumumab Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Panitumumab Consumption (2017-2022)
-
10.7.2 South Africa Panitumumab Consumption (2017-2022)
-
10.7.3 Egypt Panitumumab Consumption (2017-2022)
-
10.7.4 Algeria Panitumumab Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Panitumumab Consumption (2017-2022)
-
10.8.2 New Zealand Panitumumab Consumption (2017-2022)
11 Global Panitumumab Competitive Analysis
-
11.1 Amgen
-
11.1.1 Amgen Company Details
-
11.1.2 Amgen Panitumumab Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Amgen Panitumumab Main Business and Markets Served
-
11.1.4 Amgen Panitumumab Product Portfolio
-
11.1.5 Recent Research and Development Strategies
12 Global Panitumumab Market Outlook by Types and Applications to 2028
-
12.1 Global Panitumumab Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global 100 mg/5 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global 400 mg/20 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Panitumumab Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Panitumumab Market Analysis and Outlook to 2028
-
13.1 Global Panitumumab Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Panitumumab Consumption Forecast (2022-2028)
-
13.2.2 Canada Panitumumab Consumption Forecast (2022-2028)
-
13.2.3 Mexico Panitumumab Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Panitumumab Consumption Forecast (2022-2028)
-
13.3.2 UK Panitumumab Consumption Forecast (2022-2028)
-
13.3.3 Spain Panitumumab Consumption Forecast (2022-2028)
-
13.3.4 Belgium Panitumumab Consumption Forecast (2022-2028)
-
13.3.5 France Panitumumab Consumption Forecast (2022-2028)
-
13.3.6 Italy Panitumumab Consumption Forecast (2022-2028)
-
13.3.7 Denmark Panitumumab Consumption Forecast (2022-2028)
-
13.3.8 Finland Panitumumab Consumption Forecast (2022-2028)
-
13.3.9 Norway Panitumumab Consumption Forecast (2022-2028)
-
13.3.10 Sweden Panitumumab Consumption Forecast (2022-2028)
-
13.3.11 Poland Panitumumab Consumption Forecast (2022-2028)
-
13.3.12 Russia Panitumumab Consumption Forecast (2022-2028)
-
13.3.13 Turkey Panitumumab Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Panitumumab Consumption Forecast (2022-2028)
-
13.4.2 Japan Panitumumab Consumption Forecast (2022-2028)
-
13.4.3 India Panitumumab Consumption Forecast (2022-2028)
-
13.4.4 South Korea Panitumumab Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Panitumumab Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Panitumumab Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Panitumumab Consumption Forecast (2022-2028)
-
13.4.8 Thailand Panitumumab Consumption Forecast (2022-2028)
-
13.4.9 Singapore Panitumumab Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Panitumumab Consumption Forecast (2022-2028)
-
13.4.11 Philippines Panitumumab Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Panitumumab Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Panitumumab Consumption Forecast (2022-2028)
-
13.5.2 Colombia Panitumumab Consumption Forecast (2022-2028)
-
13.5.3 Chile Panitumumab Consumption Forecast (2022-2028)
-
13.5.4 Argentina Panitumumab Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Panitumumab Consumption Forecast (2022-2028)
-
13.5.6 Peru Panitumumab Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Panitumumab Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Panitumumab Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Panitumumab Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Panitumumab Consumption Forecast (2022-2028)
-
13.6.3 Oman Panitumumab Consumption Forecast (2022-2028)
-
13.6.4 Qatar Panitumumab Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Panitumumab Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Panitumumab Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Panitumumab Consumption Forecast (2022-2028)
-
13.7.2 South Africa Panitumumab Consumption Forecast (2022-2028)
-
13.7.3 Egypt Panitumumab Consumption Forecast (2022-2028)
-
13.7.4 Algeria Panitumumab Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Panitumumab Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Panitumumab Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Panitumumab
-
Figure of Panitumumab Picture
-
Table Global Panitumumab Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Panitumumab Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global 100 mg/5 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
Figure Global 400 mg/20 mL single-dose vials Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Stores Consumption and Growth Rate (2017-2022)
-
Figure Global Panitumumab Consumption by Country (2017-2022)
-
Table North America Panitumumab Consumption by Country (2017-2022)
-
Figure United States Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Canada Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Mexico Panitumumab Consumption and Growth Rate (2017-2022)
-
Table Europe Panitumumab Consumption by Country (2017-2022)
-
Figure Germany Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure UK Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Spain Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Belgium Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure France Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Italy Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Denmark Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Finland Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Norway Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Sweden Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Poland Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Russia Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Turkey Panitumumab Consumption and Growth Rate (2017-2022)
-
Table APAC Panitumumab Consumption by Country (2017-2022)
-
Figure China Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Japan Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure India Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure South Korea Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Thailand Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Singapore Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Philippines Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Panitumumab Consumption and Growth Rate (2017-2022)
-
Table South America Panitumumab Consumption by Country (2017-2022)
-
Figure Brazil Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Colombia Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Chile Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Argentina Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Peru Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Panitumumab Consumption and Growth Rate (2017-2022)
-
Table GCC Panitumumab Consumption by Country (2017-2022)
-
Figure Bahrain Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Oman Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Qatar Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Panitumumab Consumption and Growth Rate (2017-2022)
-
Table Africa Panitumumab Consumption by Country (2017-2022)
-
Figure Nigeria Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure South Africa Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Egypt Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure Algeria Panitumumab Consumption and Growth Rate (2017-2022)
-
Table Oceania Panitumumab Consumption by Country (2017-2022)
-
Figure Australia Panitumumab Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Panitumumab Consumption and Growth Rate (2017-2022)
-
Table Amgen Company Details
-
Table Amgen Panitumumab Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Panitumumab Main Business and Markets Served
-
Table Amgen Panitumumab Product Portfolio
-
Figure Global 100 mg/5 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 400 mg/20 mL single-dose vials Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Stores Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Panitumumab Consumption Forecast by Country (2022-2028)
-
Table North America Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure United States Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure Germany Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure China Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure Brazil Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Panitumumab Consumption Forecast by Country (2022-2028)
-
Figure Australia Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Panitumumab Consumption Forecast and Growth Rate (2022-2028)
-
